Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Fiyinfolu Balogun"'
Autor:
Ghassan K. Abou-Alfa, Mary Afihene, Marinela Capanu, Yuelin Li, Joanne F. Chou, Akwi Asombang, Olusegun Isaac Alatise, Adda Bounedjar, Lina Cunha, Hailemichael Desalegn Mekonnen, Papa Saloum Diop, Reda Elwakil, Mahamat Moussa Ali, Ntokozo Ndlovu, Jerry Ndumbalo, Precious Takondwa Makondi, Christian Tzeuton, Tiago Biachi de Castria, Adwoa Afrakoma Agyei-Nkansah, Fiyinfolu Balogun, Alain Bougouma, Blaise Irénée Atipo Ibara, Eduard Jonas, Stephen Kimani, Peter Kingham, Reshad Kurrimbukus, Nazik Hammad, Mona Fouad, Noha El Baghdady, Eloumou Bagnaka Servais Albert Fiacre, Vikash Sewram, C. Wendy Spearman, Ju Dong Yang, Lewis R. Roberts, Ashraf O. Abdelaziz
Publikováno v:
JCO Global Oncology, Vol , Iss 9 (2023)
PURPOSEHepatocellular carcinoma (HCC), the fourth most common cancer in Africa, has a dismal overall survival of only 3 months like in sub-Saharan Africa. This is affected by the low gross domestic product and human development index, absence of cohe
Externí odkaz:
https://doaj.org/article/bb11425805f648a1a198b8b80e8b96bf
Autor:
Eileen M. O'Reilly, Christine Iacobuzio-Donahue, Marinela Capanu, Christopher Crane, David P. Kelsen, Kenneth H. Yu, Fiyinfolu Balogun, Fergus Keane, Anna M. Varghese, Marsha Reyngold, Shigeaki Umeda, Joanne F. Chou, Daniella Forman, Chaitanya Bandlamudi, Catherine A. O'Connor, Wungki Park
Supplementary Figure from Clinico-genomic Characterization of ATM and HRD in Pancreas Cancer: Application for Practice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d02dd03e584fdd44e38ae775d950cad
https://doi.org/10.1158/1078-0432.22488417
https://doi.org/10.1158/1078-0432.22488417
Autor:
Eileen M. O'Reilly, Christine Iacobuzio-Donahue, Marinela Capanu, Christopher Crane, David P. Kelsen, Kenneth H. Yu, Fiyinfolu Balogun, Fergus Keane, Anna M. Varghese, Marsha Reyngold, Shigeaki Umeda, Joanne F. Chou, Daniella Forman, Chaitanya Bandlamudi, Catherine A. O'Connor, Wungki Park
Supplementary Data from Clinico-genomic Characterization of ATM and HRD in Pancreas Cancer: Application for Practice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0550dabfb72da97336c9727af9f81a06
https://doi.org/10.1158/1078-0432.22488435.v1
https://doi.org/10.1158/1078-0432.22488435.v1
Autor:
Eileen M. O'Reilly, Christine Iacobuzio-Donahue, Marinela Capanu, Christopher Crane, David P. Kelsen, Kenneth H. Yu, Fiyinfolu Balogun, Fergus Keane, Anna M. Varghese, Marsha Reyngold, Shigeaki Umeda, Joanne F. Chou, Daniella Forman, Chaitanya Bandlamudi, Catherine A. O'Connor, Wungki Park
Purpose:Characterizing germline and somatic ATM variants (gATMm, sATMm) zygosity and their contribution to homologous recombination deficiency (HRD) is important for therapeutic strategy in pancreatic ductal adenocarcinoma (PDAC).Experimental Design:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af45f3d05c721b60d9d261257f758660
https://doi.org/10.1158/1078-0432.c.6532713
https://doi.org/10.1158/1078-0432.c.6532713
Autor:
Wungki Park, Catherine A. O'Connor, Chaitanya Bandlamudi, Daniella Forman, Joanne F. Chou, Shigeaki Umeda, Marsha Reyngold, Anna M. Varghese, Fergus Keane, Fiyinfolu Balogun, Kenneth H. Yu, David P. Kelsen, Christopher Crane, Marinela Capanu, Christine Iacobuzio-Donahue, Eileen M. O'Reilly
Publikováno v:
Clin Cancer Res
Purpose: Characterizing germline and somatic ATM variants (gATMm, sATMm) zygosity and their contribution to homologous recombination deficiency (HRD) is important for therapeutic strategy in pancreatic ductal adenocarcinoma (PDAC). Experimental Desig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2dee3aa9e1e5cce02e31dcd94645b67e
https://pubmed.ncbi.nlm.nih.gov/36040493
https://pubmed.ncbi.nlm.nih.gov/36040493
Adjuvant modified FOLFIRINOX (mFFX) for resected pancreatic cancer (PDAC): Real world outcomes (RWO)
Autor:
Fergus Keane, Fiyinfolu Balogun, Catherine O'Connor, Fionnuala Crowley, Amelia Chan, Darren Cowzer, Joanne F. Chou, Wungki Park, Anna M. Varghese, Kenneth H. Yu, James J. Harding, Marinela Capanu, Jeffrey A. Drebin, T. Peter Kingham, Michael Ian D'Angelica, Vinod P. Balachandran, William R. Jarnagin, Alice Chia-chi Wei, Kevin Soares, Eileen Mary O'Reilly
Publikováno v:
Journal of Clinical Oncology. 41:685-685
685 Background: Adjuvant mFFX (5-fluorouracil, leucovorin, irinotecan, oxaliplatin) is a standard-of-care for fit patients (pts) with resected PDAC, owing to the immediate practice-changing PRODIGE 24/CCTG PA6 trial (2018). Five-year follow-up: media
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ffb5811785ff12abc42185b48a74038f
https://doi.org/10.1200/jco.2023.41.4_suppl.685
https://doi.org/10.1200/jco.2023.41.4_suppl.685
Autor:
Grainne O'Kane, Teresa Macarulla, Fiyinfolu Balogun, Antoine Hollebecque, Matthew J. Reilley, Sreenivasa R. Chandana, Jim Eyles, Oluwaseun Ojo, Philip Overend, Douglas C. Palmer, Nadia Luheshi, Mayukh Das, Antoine Italiano, Joan Seoane
Publikováno v:
Cancer Research. 82:CT126-CT126
Background: Leukemia inhibitory factor (LIF) is an immunosuppressive cytokine linked to tumor growth and metastasis. LIF overexpression correlates with poor prognosis and chemoresistance in multiple tumor types including PDAC. Preclinical data show t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c1f0a579296a6d4c05df4961f37e1f36
https://doi.org/10.1158/1538-7445.am2022-ct126
https://doi.org/10.1158/1538-7445.am2022-ct126
Autor:
Lidong Wang, Annie Wang, Mohammad Sohail, Ende Zhao, Agnel Sfeir, Fiyinfolu Balogun, Diane M. Simeone, Daniel Diolaiti, Jiufeng Li, Andrea Zamperone
Publikováno v:
Cancer Research. 79:I14-I14
Recent genomic characterization of PDA reveals that between 20-25 % of PDA harbor recurrent mutations in genes, including BRCA1/2, PALB2, and ATM, which are critical for homologous recombination (HR), an important form of DNA repair. In many patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::994424f5f32e06af47b5ebed825df33d
https://doi.org/10.1158/1538-7445.panca19-i14
https://doi.org/10.1158/1538-7445.panca19-i14
Autor:
Fiyinfolu Balogun, Louis J. Ptáček, T’Prien Stoffer, Vittorio Maglione, Elizabeth Huang, Jon S. Zawistowski, Adrian M. Siegel, Nicholas W. Plummer, Tracey P. Leedom, Eric W. Johnson, Dominique J. Verlaan, Christina L. Liquori, Lori Hughes, Ferdinando Squitieri, Douglas A. Marchuk, Michel J. Berg, Milena Cannella, Guy A. Rouleau
Publikováno v:
The American Journal of Human Genetics. 73(6):1459-1464
Cerebral cavernous malformations (CCMs) are congenital vascular anomalies of the central nervous system that can result in hemorrhagic stroke, seizures, recurrent headaches, and focal neurologic deficits. Mutations in the gene KRIT1 are responsible f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c85573c052210efee778219c26686896